Multnomah County Health Department in Oregon reports tuberculosis
On May 15, 2025, the Multnomah County Health Department in Oregon reports an individual at Lane Middle School…
Biotechnology | Diagnostics | HIV | Infectious Disease | Influenza | Measles | NIH | Oncology | Vaccine
NIH to end billions of dollars in foreign research grants
On May 1, 2025, the U.S. National Institutes of Health (NIH), the world’s largest funder of biomedical research,…
End of U.S. Global Health Funding Could Result in 25 Million Deaths
On Apr. 17, 2025, a study was published that shows the United States spent roughly US$12 billion on…
A new smartphone-sized device can test for tuberculosis
On Apr. 9, 2025, Tulane University researchers announced they have developed a first-of-its-kind handheld diagnostic device that can…
Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test
On Apr. 2, 2025, Revvity announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure…
WHO calls for immediate action as report shows 10% rise in child TB infections in European region
On Mar. 24, 2025, Tuberculosis (TB) infections among children in the European region rose 10% in 2023, indicating…
Funding cuts impact access to TB services endangering millions of lives
On Mar. 5, 2025, the World Health Organization (WHO) announced In the past two decades, tuberculosis (TB) prevention,…
Biotechnology | HIV | Infectious Disease | Influenza | Measles | NIH
U.S. foreign aid freeze deals ‘tectonic’ blow to research around the globe
On Feb. 5, 2025, the proposed dismantling of the U.S. Agency for International Development (USAID) could disrupt clinical…
tuberculosis outbreak from 2024 Ongoing in Kansas
On Jan. 31, 2025, the Kansas Department of Health and Environment (KDHE) reported that there were 67 confirmed…
WHO announced first prequalification of a tuberculosis diagnostic test
On Dec. 5, 2024, the World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for…
Biotechnology | HIV | Infectious Disease | Medicine | Vaccine | WHO
WHO study lists top endemic pathogens for which new vaccines are urgently needed
On Nov. 5, 2024, a World Health Organization (WHO) study published in eBioMedicine named 17 pathogens that regularly…
Tuberculosis resurges as top infectious disease killer
On Oct. 29, 2024, the World Health Organization (WHO) published a report on tuberculosis revealing that approximately 8.2…
Novo Nordisk Foundation announced USD $260 million vaccines initiative to fight deadly airborne infections
On Dec. 18, 2023, the Novo Nordisk Foundation announced it was committing up to DKK 1.8 billion (USD…
U.S. Centers for Disease Control and Prevention Tuberculosis Trials Consortium launched new TB clinical trial
On Nov. 27, 2023, the CDCﾒs Tuberculosis Trials Consortium (TBTC) announced that it had launched an international clinical…
U.S. Preventive Services Task Force recommended screening for latent tuberculosis infection
On May 2, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
Biotechnology | CDC | COVID-19 | Diagnostics | Vaccine
Tuberculosis in the U.S. increased slightly during 2022 although it remained lower than prepandemic years
On Mar. 24, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Tuberculosis (TB) in…
Abbott received FDA clearance for first commercially available lab-based blood test to help evaluate concussion
On Mar. 7, 2023, Abbott announced that it had received U.S. Food and Drug Administration clearance for what…
Tuberculosis deaths and disease increased during the COVID-19 pandemic
On Oct. 27, 2022, the World Health Organization reported that an estimated 10.6 million people fell ill with…
IAVI and Moderna partnered to tackle broad global health priorities using mRNA for vaccines and antibodies
On Apr. 7, 2022, Moderna and IAVI announced a collaboration to employ mRNA technology to meet the challenge…
NIH funded new tuberculosis research advancement centers
On Mar. 9, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced four grant awards to…
Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
Largest ever global study of tuberculosis identified genetic causes of drug resistance
On Oct. 19 , 2021, researchers at the University of Oxford, using cutting-edge genomic sequencing techniques, announced they…
Tuberculosis deaths rose for the first time in more than a decade due to the COVID-19 pandemic
On Oct. 14, 2021, the World Health Organization announced that the COVID-19 pandemic had reversed years of global…
Twist Bioscience single domain antibody TB202-3 showed potent binding to multiple strains of SARS-CoV-2
On Sept. 23, 2021, Twist Bioscience reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to…
The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis C
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
U.S. FDA approved TICOVACﾙ, Pfizerﾒs tick-borne encephalitis vaccine
On Aug. 13, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved TICOVACﾙ (tick-borne…
Rice, Rutgers announced development of inhalable COVID-19 vaccine spray
On Jul. 7, 2021, Rice University announced a study to develop an inhalable COVID-19 vaccine. The project led…
BD announced assay for identification of COVID-19 patients at increased risks of intubation available in Europe
On Feb. 3, 2021, BD (Becton, Dickinson) announced the CE mark of BD Multitestﾙ 6-Color TBNK Reagent with…
Abbott announced fulfillment of Federal government purchase of 150 million BinaxNOWﾙ COVID-19 Rapid Tests
On Jan. 12, 2021, Abbott announced it had received FDA 510(k) clearance for the first rapid handheld traumatic…
Abbott received CE Mark for its COVID-19 IgG quantitative antibody blood test
On Jan. 11, 2021, Abbott announced it had received FDA 510(k) clearance for the first rapid handheld traumatic…